Compare GEVO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEVO | LAB |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.8M | 354.1M |
| IPO Year | 2010 | 2008 |
| Metric | GEVO | LAB |
|---|---|---|
| Price | $1.72 | $0.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.42 | $1.35 |
| AVG Volume (30 Days) | ★ 4.4M | 2.6M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.82 | ★ 61.54 |
| EPS | ★ N/A | N/A |
| Revenue | $711,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $19.44 | N/A |
| Revenue Next Year | $5.59 | $2.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.87 |
| 52 Week High | $2.97 | $1.72 |
| Indicator | GEVO | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 45.23 |
| Support Level | $1.61 | $0.92 |
| Resistance Level | $1.89 | $1.01 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 1.94 | 48.54 |
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.